Skip to main content
OpenTrials

Clinical trial condition

Multiple Endocrine Neoplasia Type 1

Explore clinical trials studying Multiple Endocrine Neoplasia Type 1. Study availability and eligibility vary by location and protocol.

160 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Multiple Endocrine Neoplasia Type 1 trial results

Completed

A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally

NCT05071729

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +11 more
Locations
  • Clinical Pharmacology of Miami, LLC Miami, Florida, United States
  • Orlando Clinical Research Center Orlando, Florida, United States
View Trial Details
Completed

Protein-Prebiotic Wellbeing Study

NCT05303753

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive Health, Endocrine Gland Neoplasms, +9 more
Locations
  • Arizona State University Phoenix, Arizona, United States
View Trial Details
Completed

HPV Vaccine Intervention for Young Sexual Minority Men

NCT04032106

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +8 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

NCT03452111

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +10 more
Locations
  • UC Davis Health Sacramento, California, United States
  • The Lunquist Institute at Harbor-UCLA Medical Center Torrance, California, United States
  • Comprehensive Women's Health Center Denver, Colorado, United States
  • University of Kansas Kansas City, Kansas, United States
View all 17 locations
View Trial Details
Completed

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.

NCT02437318

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
View all 197 locations
View Trial Details

Related conditions